NeurAxon's Unattributed VC Round

NeurAxon raised a round of funding on , . Investors include Covington Funds.

NeurAxon is discovering and developing next generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous s…

Articles about NeurAxon's Unattributed VC Round: